Physician profile
Asim Rafique
NPI 1497078752
$1,814.94
in general payments reported to CMS, 2019-2025
13 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $75.47 · 2021: $114 · 2022: $419 · 2023: $347 · 2024: $175 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550 · Travel and Lodging: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.42 |
| Travel and Lodging | $201.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $319.24 | 2022 | |
| Abiomed | $306.25 | 2019-2020 | |
| Medtronic, INC. | $295.53 | 2023-2025 | Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $218.47 | 2019-2023 | Pressurewire, Coroflow |
| Boston Scientific Corporation | $210.58 | 2025 | Emerge Push, Synergy |
| Pfizer INC. | $139.61 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $123.03 | 2024 | Xarelto |
| W. L. Gore & Associates, INC. | $59.81 | 2021-2022 | |
| Edwards Lifesciences Corporation | $52.23 | 2024 | Pascal |
| Acist Medical Systems, INC. | $38.52 | 2021-2022 | |
| Chiesi USA, INC. | $28.02 | 2019 | |
| Biotronik INC. | $23.65 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asim Rafique listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.